Erythroferrone inhibits the induction of hepcidin by BMP6

Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization

Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803

Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis

Makker, J. S., Hanif, A., Bajantri, B., & Chilimuri, S. S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,353

Identification of erythroferrone as an erythroid regulator of iron metabolism

Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127

Hepcidin and iron regulation, 10 years later

Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter

Korchynskyi, O., & ten Dijke, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111023200 · Cited by 876

BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism

Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769

Lack of the bone morphogenetic protein BMP6 induces massive iron overload

Meynard, D., Kautz, L., Darnaud, V., Canonne-Hergaux, F., Coppin, H., & Roth, M.-P. (2009) · Nature Genetics · doi:10.1038/ng.320 · Cited by 587

Suppression of hepcidin during anemia requires erythropoietic activity

Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472

Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors

Cuny, G. D., Yu, P. B., Laha, J. K., Xing, X., Liu, J.-F., Lai, C. S. C., Deng, D. Y., Sachidanandan, C., Bloch, K. D., & Peterson, R. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.052 · Cited by 351

Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin

Aschemeyer, S., Qiao, B., Stefanova, D., Valore, E. V., Sek, A. C., Ruwe, T. A., Vieth, K. R., Jung, G., Casu, C., Rivella, S., et al. (2018) · Blood · doi:10.1182/blood-2017-05-786590 · Cited by 325

[Expression of iron-regulating erythroid factors in different types of erythropoiesis disorders].

Liu, X., Hu, J. Y., Hu, X., Li, X. X., Guan, D., Liu, J. Q., Zhang, Y. L., & Zhang, F. K. (2021) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2021.01.010 · Cited by 4

Calcitonin increases hepatic hepcidin expression through the BMP6 of kidney in mice

Lei, Y., Zhao, C., Chang, H., Zhang, D., Li, Y., Anderson, G. J., Shen, Y., Duan, X., & Chang, Y. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126796 · Cited by 4

The diagnostic potential of the iron‐regulatory hormone hepcidin

Armitage, A. E., & Drakesmith, H. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000236 · Cited by 4

Iron homeostasis governs erythroid phenotype in Polycythemia VeraPreprint

Bennett, C., Jackson, V. E., Pettikiriarachchi, A., Hayman, T., Schaeper, U., Moir-Meyer, G., Fielding, K., Ataíde, R., Clucas, D. B., Baldi, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.03.490556 · Cited by 4

Erythroferrone derived from osteoblasts regulates stress erythropoiesis

Na-Phatthalung, P., van Caloen, G., Planoutene, M., Tai, E., Gumerova, A. A., Witztum, R., Ingber, E., Kautz, L., Sultana, F., Korkmaz, F., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2537627123 · Cited by 4

Effects of Exogenous Transferrin on the Regulation of Iron Metabolism and Erythropoiesis in Iron Deficiency With or Without Anemia

Li, Y., Miller, I. J., Prasad, P., George, N. A., Parrow, N. L., & Fleming, R. E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.893149 · Cited by 3

Iron and Pregnancy

Sangkhae, V., & Nemeth, E. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_21 · Cited by 5

Novel Insights and Future Perspective in Iron Metabolism and Anemia

Andolfo, I., & Russo, R. (2022) · Metabolites · doi:10.3390/metabo12020138 · Cited by 3

Iron Biology: Metabolism and Homeostasis

Ganz, T. (2022) · Nutrition and health · doi:10.1007/978-3-031-14521-6_2 · Cited by 3

Early erythroferrone levels can predict the long‐term haemoglobin responses to erythropoiesis‐stimulating agents

Xu, P., Wong, R. S. M., & Yan, X. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16396 · Cited by 4

Serum erythroferrone levels during the first month of life in premature infants

Lenhartová, N., Ochiai, M., Sawano, T., Yasuoka, K., Fujiyoshi, J., Inoue, H., & Ohga, S. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-01184-6 · Cited by 3

ERFE regulation in sickle cell disease: complex but promising

Girelli, D., & Busti, F. (2020) · British Journal of Haematology · doi:10.1111/bjh.16527 · Cited by 3

Serum Intact and Total Fibroblast Growth Factor 23 Levels and Iron-related Parameters in Hemodialysis Patients

Tanaka, K. (2022) · Journal of Clinical and Medical Research · doi:10.37191/mapsci-2582-4333-4(5)-124 · Cited by 3

Genome-wide meta-analysis of iron status biomarkers and the effect of iron on all-cause mortality in HUNTPreprint

Moksnes, M. R., Hansen, A. F., Graham, S. E., Taliun, S. A. G., Wu, K.-H., Zhou, W., Thorstensen, K., Fritsche, L. G., Gill, D., Mason, A. M., et al. (2021) · medRxiv · doi:10.1101/2021.09.20.21262960 · Cited by 3

Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease

Woźniak, M., Borkowska, A., Jastrzębska, M., Sochal, M., Małecka-Wojciesko, E., & Talar‐Wojnarowska, R. (2023) · Metabolites · doi:10.3390/metabo13091006 · Cited by 2

Control of Systemic Iron Homeostasis: Insights Gained from Studying Mouse Models

Altamura, S., & Muckenthaler, M. U. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92033-2_8 · Cited by 2

Hepatokine FGL1 and hepcidin in anemia of chronic kidney disease: A cross sectional study

Saboor, M., Hashim, H. N., Guella, A., & Alkhayyal, N. (2025) · Journal of King Saud University - Science · doi:10.25259/jksus_1251_2025 · Cited by 2

Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP–SMAD Signaling to Therapeutic Modulation

Duminuco, A., Costa, A. N., Pilo, F., Scarso, S., Giallongo, C., Giallongo, S., Santisi, A., Sbriglione, A., Santocono, L., Caocci, G., et al. (2026) · Biomolecules · doi:10.3390/biom16070947 · Cited by 2

Liver Hormones

Cocciolillo, S., Sebastiani, G., Blostein, M. D., & Pantopoulos, K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00018-3 · Cited by 2

Induction of Hepcidin Expression in the Renal Cortex of Sickle Cell Disease Mice

Ahmad, A., Kumari, N., Afangbedji, N. K. A., Nekhai, S. A., & Jerebtsova, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310806 · Cited by 8

Understanding iron homeostasis in MDS: the role of erythroferrone

Abba, M. L., Riabov, V., Nowak, D., Hofmann, W., & Boch, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1404817 · Cited by 3

Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model

Zhang, H., Liu, R., Fang, Z., Nie, L., Ma, Y., Sun, F., Mei, J., Song, Z., Ginzburg, Y. Z., Liu, J., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024012679 · Cited by 2

Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Erythroferrone in Anemic Rats with Chronic Kidney Disease and Chemotherapy-Induced Anemia: An Early Biomarker for Hemoglobin Response and rHuEPO Hyporesponsiveness

Zhang, L., Xu, P., & Yan, X. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00575 · Cited by 2

HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease

Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2025) · Biomedicines · doi:10.3390/biomedicines13030683 · Cited by 2

Drugging erythroferrone to treat anemias

Ganz, T. (2020) · Blood · doi:10.1182/blood.2019004678 · Cited by 2

Single-cell RNA seq analysis of erythroid cells reveals a specific sub-population of stress erythroid progenitors

Fomukong, H. A., Kalu, M., Aimola, I. A., Sallau, A. B., Bello‐Manga, H., Gouegni, E. F., Ameloko, J. U., Kudan, Z. B., Alfa, D. U., & Baba, R. S. (2023) · Hematology · doi:10.1080/16078454.2023.2261802 · Cited by 2

Effect of Recombinant Human Erythroferrone Protein on Hepcidin Gene (Hamp1) Expression in HepG2 and HuH7 Cells

Than, M. M., Koonyosying, P., Ruangsuriya, J., Junrungsee, S., Uthaipibull, C., & Srichairatanakool, S. (2021) · Materials · doi:10.3390/ma14216480 · Cited by 2

Ebola and Marburg Virus Infection in Bats Induces a Systemic Response

Jayaprakash, A. D., Ronk, A. J., Prasad, A. N., Covington, M. F., Stein, K. R., Schwarz, T. M., Hekmaty, S., Fenton, K. A., Geisbert, T. W., Basler, C. F., et al. (2020) · Viruses · doi:10.3390/v15020350 · Cited by 18

The hepatokine FGL1 regulates hepcidin and iron metabolism during the recovery from hemorrhage-induced anemia in micePreprint

Sardo, U., Perrier, P., Cormier, K., Sotin, M., Desquesnes, A., Cannizzo, L., Ruíz-Martínez, M., Thevenin, J., Billoré, B., Jung, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.06.535920 · Cited by 2

Mechanisms, mishaps and manipulation of iron uptake

Bennett, C., & Pasricha, S. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000237 · Cited by 1

Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant

Gök, V., Özcan, A., Özer, S., Karaman, F., Aykutlu, E., Yilmaz, E. A., Karakükçü, M., Bişgin, A., & Ünal, E. (2022) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2022.2140235 · Cited by 1

Molecular Insights into the Pathophysiology of Dysregulated Erythropoiesis: The Crucial Role of Iron Homeostasis

Fujiwara, T., & Harigae, H. (2025) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2553648 · Cited by 1

Erythroferrone and its role in the iron metabolism regulation: molecular mechanisms and clinical significance

Elkina, A. Y., Sheptulina, A. F., & Drapkina, O. M. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202528101123 · Cited by 1

Redox Modulation of Erythropoiesis by Selenoproteins

Gong, H., Paulson, R. F., & Prabhu, K. S. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04923-4 · Cited by 1

Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan

Babar, S., Siddiqi, M. Y. J., Rizwan, M., Ahmed, S., & Saboor, M. (2026) · Hemoglobin · doi:10.1080/03630269.2026.2637574 · Cited by 1

Iron-refractory iron deficiency anemia

Finberg, K. E. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100080 · Cited by 1

Uncoupling Erythropoiesis from Cardiorenal Effects: SGLT2 Inhibition in Non-Diabetic Heart Failure

Măgureanu, D. C., Bocșan, I. C., Pop, R. M., Neag, M. A., Cozma, A., & Buzoianu, A. D. (2026) · Medicina · doi:10.3390/medicina62050993 · Cited by 1

Erythroferrone in β-thalassemia: Systematic review and meta-analysis

Saboor, M., & Abass, K. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.121179 · Cited by 1

Erythropoietin Concentration in Boys With p.His63Asp Polymorphism of the HFE Gene

Kaczorowska-Hac, B., Łuszczyk, M., Wasilewska, E., Antosiewicz, J., & Kaczor, J. J. (2021) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002126 · Cited by 1

Anemia of inflammatory: does eiderr knowledge mean better diagnosis and treatment?

Tupý, J. (2023) · Vnitřní lékařství · doi:10.36290/vnl.2023.023 · Cited by 2

Iron and Heart Failure: Current Concepts and Emerging Pharmacological Paradigms

Pascale, M. R. D., Rondinelli, M. B., Ascione, F., Maffei, V., Lorenzo, C. D., Scagliarini, S., Faraonio, R., & Faiella, A. (2024) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2024.144016 · Cited by 1

A deep dive into future therapies for microcytic anemias and clinical considerations

Rodrigues, F., Coman, T., Fouquet, G., Côté, F., Courtois, G., Maciel, T. T., & Hermine, O. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2206556 · Cited by 1

Crosstalk Between Iron and Bone Metabolism: Evidence from Patients and Mouse Models of β-Thalassemia

Castro-Mollo, M. W., Feola, M., & Ginzburg, Y. Z. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11557-0 · Cited by 1

BMP5: a novel tile of the hepcidin regulatory pathway

Nai, A. (2023) · Blood · doi:10.1182/blood.2023021643 · Cited by 1

Codon-Optimized FAM132b Prevents Diet-Induced Obesity by Modulating Adrenergic Response and Insulin ActionPreprint

Qi, Z., Xia, J., Xue, X., Liu, W., Huang, Z., Zhang, X., Zou, Y., Liu, J., Liu, J., Li, X., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3708518

Hereditary anemias: more complex than ever

van Vuren, A. J. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/429

Peer Review #2 of "Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.8802v0.1/reviews/2

Peer Review #3 of "Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.8802v0.2/reviews/3

Peer Review #2 of "Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.8802v0.2/reviews/2

Peer Review #1 of "Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.8802v0.2/reviews/1

Peer Review #3 of "Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.8802v0.1/reviews/3

Peer Review #1 of "Iron homeostasis in a mouse model of thalassemia intermedia is altered between adolescence and adulthood (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.8802v0.1/reviews/1

Influencia de las hormonas sexuales en la respuesta de la hepcidina y la homeostasis del hierro al ejercicio de resistencia en mujeres deportistas: Proyecto IronFEMME = Influence of sex hormones on the hepcidin and iron homeostasis response to endurance exercise in women athletes: IronFEMME study

Alfaro-Magallanes, V. M. (2022) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.71841

FGL1, une nouvelle cible pour le traitement de l’anémie ?

Medjbeur, T., Personnaz, J., & Kautz, L. (2024) · médecine/sciences · doi:10.1051/medsci/2024123

Effect of 2‐h hypoxic exposure on resting hepcidin levels in young adults

Lin, C.-A., Naruse, M., Tomiishi, C., Matsudo, H., Badenhorst, C. E., & Goto, K. (2025) · Physiological Reports · doi:10.14814/phy2.70530

Role of Iron in Metabolic Disorders via ROS Influence on Inflammation

Chaudhary, P., Madan, A., Saxena, D., Kriti, K., Singh, S., Bhise, M. R., Mondal, M., Chakraborty, A. J., & Debnath, B. (2026) · Springer eBooks · doi:10.1007/978-3-032-11752-6_18

The Dysregulation of Iron Homeostasis in Obesity

Ramasamy, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_115-1 · Cited by 1

Erythroferrone is associated with the hepcidin-to-ferritin ratio and cardiovascular mortality in chronic kidney disease

Danielson, K., Qureshi, A. R., Beshara, S., Lindholm, B., Stenvinkel, P., & Barany, P. F. (2026) · Clinical Kidney Journal · doi:10.1093/ckj/sfag075

Erythroferrone as a Predictor of Bone Mineral Density and Fracture Risk in Adults with Transfusion-Dependent β-Thalassemia

Abdalla, N. E.-H. H., Zimity, M. A., Eldeen, H. M., & Mohamed, H. S. (2026) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-026-02387-7

Etude du récepteur à la transferrine de type 2 dans l'érythropoïese.

Richard, C. (2019) · theses.fr (ABES) · doi:10.70675/c36ec54fz3a93z404cz8641z05a8f1db21d5

La sérotonine intestinale : un acteur essentiel de la régulation de l'homéostasie du fer

Falabrègue, M. (2020) · theses.fr (ABES) · doi:10.70675/911bf09czfa11z4227zacfaz2f72ec7a7582

Le rôle de l'érythroferrone dans la régulation du métabolisme du fer

Sardo, U. (2020) · theses.fr (ABES) · doi:10.70675/d03e67aczc44bz4af9z8fa1zef080668f44f

Régulation du métabolisme du fer et nouvelles stratégies thérapeutiques

Belot, A. (2020) · theses.fr (ABES) · doi:10.70675/14758a3dze368z4da8zbee5z91e1a5d383fa

Impact of Iron Metabolism Disorders on Post-Renal Transplantation Complications

刘, 晓. (2026) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2026.52166

Erythroferrone Modulates Osteoblast-Osteoclast Crosstalk During Bone RemodelingPreprint

Na-Phatthalung, P., van Caloen, G., Planoutene, M., Tai, E., Gumerova, A. A., Pevnev, G., Cao, J., Witztum, R., Ingber, E., Kautz, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.05.722997

Erythroferrone antagonism of BMPs is governed by a composite heparin-binding motif

Mast, E. M., Hok, L., Leach, E., & Thompson, T. B. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113250

18β-Glycyrrhetinic acid ameliorates renal anemia via inactivating PHD2 and activating HIF-2α-EPO axis

Li, J., Han, K., Fu, Y., Zhao, C., Yin, S., & Hu, H. (2026) · Food Research International · doi:10.1016/j.foodres.2026.119713

Sappanwood extract modulates hepatic structure–function in hepatomegaly and hepcidin related iron regulatory pathways in a phenylhydrazine induced hemolytic anemia rat model relevant to thalassemia

Pratama, M. I., Safitri, R., Malini, D. M., Syamsunarno, M. R. A. A., Ghozali, M., & Madihah, M. (2026) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70264

Compensated iron depletion in repeated blood donations: Stability of circulating microRNAs despite reduced ferritin stores

Karaca, A., Çitli, Ş., Arpa, M., & Sönmez, K. (2026) · Vox Sanguinis · doi:10.1111/vox.70344

Regulation of erythroid development by iron metabolism

Ishfaq, M., & Yien, Y. Y. (2026) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2026.06.005

Could Hepcidin Be a Phenotype-Related Biomarker in Patients with Stable Bronchiectasis?

Yilmaz, G., Çoban, H., Erel, F., Akış, M., Sarıoğlu, N., Colak, M., Şenel, M. Y., & Elmalı, A. D. M. (2026) · Life · doi:10.3390/life16091439

Inherited microcytic anemias due to disorders of iron and heme metabolism: An updated clinical review

Makis, A. C., Saougou, I., & Hatzimichael, E. C. (2026) · HemaSphere · doi:10.1002/hem3.70465

Iron Supplementation and Copper Homeostasis: Evidence for Potential Copper Depletion, Biomarker Challenges, and Clinical Implications

Lee, J., & Ha, J. (2026) · Nutrients · doi:10.3390/nu18193117

FGL1–hepcidin axis in iron homeostasis and disease

Saboor, M., Rahim, R. A., Dad, S. N., Mansoor, H. M., Nasser, M. M., & Yusuf, A. M. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.122859

Cyclical Iron Homeostasis: The Role of Sex Hormones in Female Iron Regulation

Balakirishnan, D., Dukovski, F., Bytheway, H. G., & Dugan, C. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl54404

Placental Iron Homeostasis: Navigating the Delicate Balance Between Transport and Ferroptosis

Szukiewicz, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198856

Iron Homeostasis and Liver Diseases

Yang, P., Shi, Z. X., Huang, Q., Tu, Z., Sun, Y., Wang, L., & Wei, Y. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71412

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice

Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97

Inactivation of Tmprss6 Hampers Hepcidin Inhibition By Erythroferrone through Upregulation of the BMP-SMAD Pathway

Silvestri, L., Nai, A., Campanella, A., Artuso, I., Bordini, J., & Camaschella, C. (2015) · Blood · doi:10.1182/blood.v126.23.408.408

Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3

Wang, C., Xu, Y., Traeger, L., Dogan, D. Y., Xiao, X., Steinbicker, A. U., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood.2019002620 · Cited by 100

Iron, erythropoietin, and inflammation regulate hepcidin in Bmp2‐deficient mice, but serum iron fails to induce hepcidin in Bmp6‐deficient mice

Wang, C., Canali, S., Bayer, A. L., Dev, S., Agarwal, A., & Babitt, J. L. (2018) · American Journal of Hematology · doi:10.1002/ajh.25366 · Cited by 33

Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly

Gammella, E., Diaz, V., Recalcati, S., Buratti, P., Samaja, M., Dey, S., Noguchi, C. T., Gassmann, M., & Cairo, G. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00410.2014 · Cited by 59